a combination of (i) an amount of at least one compound effective for agonizing a melanocortin-receptor selected from MC- 1 R and MC-4R, and (ii) an amount of at least one compound effective for inhibiting cAMP phosphodiesterase." Specific disclosures are only to PDE-3, -4, -7 or -8 inhibitors, and a number of specific diseases are disclosed (e.g., inflammatory bowel disease, rheumatoid arthritis, asthma, etc.), but not sexual dysfunction
Savarino E, Zentilin P, Mastracci L, et al
Luckily there are other ways to determine deficiencies (we will go over lab work below) like your symptoms
Orr WC, Chen CL, Sloan S
Most Kybella patients need 3 to 5 days of social downtime due to visible swelling
If you use a continuous glucose monitor (CGM), set tighter alert ranges during weeks 3 to 6 to catch unexpected spikes early